Skip Navigation

Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more

Filter Results

1297 News Releases Found

Eric Smith, MD, PhD
News Releases
9/28/2022

CAR T-Cell Therapy Targeting GPRC5D Antigen Proves Effective in First Trial in Patients with Resistant Multiple Myeloma

  • Immunotherapy
  • Multiple Myeloma
News Releases
9/28/2022

Dana-Farber joins Parker Institute for Cancer Immunotherapy to accelerate cures for the world’s gravest cancers

  • Immunotherapy
Irene Ghobrial, MD, in her lab
News Releases
9/23/2022

Study illuminates precancerous “clonal outgrowth” in blood cells

  • Research
  • Blood Cancer
_
News Releases
9/21/2022

2022 WEEI/NESN Jimmy Fund Radio-Telethon presented by Arbella Insurance raised more than $3.5 million in 36-hour broadcast

_
News Releases
9/21/2022

Count Me In launches a rare cancer research project to engage leiomyosarcoma patients and families

  • Sarcoma
News Releases
9/16/2022

Many US families of children with leukemia may experience food insecurity

  • Inclusion, Diversity & Equity
  • Stem Cell/Bone Marrow Transplant, Childhood
_
News Releases
9/15/2022

Newsweek Names Dana-Farber #4 in the World for Cancer

Arthur T. Skarin, MD
News Releases
9/8/2022

In Memoriam: Arthur T. Skarin, MD, Physician-Scientist Instrumental in Building Dana-Farber’s Adult Oncology Program

Toni K. Choueiri, MD
News Releases
9/7/2022

Three-drug combination slows progression of advanced kidney cancer

  • Research
  • Immunotherapy
  • Kidney Cancer